Stroke-Associated Pneumonia: Major Advances and Obstacles

Cerebrovascular Diseases - Tập 35 Số 5 - Trang 430-443 - 2013
Yousef Hannawi1, Bashar Hannawi2, Chethan P. Venkatasubba Rao3, José I. Suárez3, Eric M. Bershad3
1Department of Neurology, Baylor College of Medicine, Houston, TX, USA. yousefhannawi yahoo.com
2Houston Methodist Hospital
3Baylor college of Medicine;

Tóm tắt

<b><i>Background:</i></b> Stroke-associated pneumonia (SAP) has been implicated in the morbidity, mortality and increased medical cost after acute ischemic stroke. The annual cost of SAP during hospitalization in the United States approaches USD 459 million. The incidence and prognosis of SAP among intensive care unit (ICU) patients have not been thoroughly investigated. We reviewed the pathophysiology, microbiology, incidence, risk factors, outcomes and prophylaxis of SAP with special attention to ICU studies. <b><i>Methods:</i></b> To determine the incidence, risk factors and prognosis of acute SAP, PubMed was searched using the terms ‘pneumonia' AND ‘neurology intensive unit' and the MeSH terms ‘stroke' AND ‘pneumonia'. Non-English literature, case reports and chronic SAP studies were excluded. Studies were classified into 5 categories according to the setting they were performed in: neurological intensive care units (NICUs), medical intensive care units (MICUs), stroke units, mixed studies combining more than one setting or when the settings were not specified and rehabilitation studies. <b><i>Results:</i></b> The incidences of SAP in the following settings were: NICUs 4.1-56.6%, MICUs 17-50%, stroke units 3.9-44%, mixed studies 3.9-23.8% and rehabilitation 3.2-11%. The majority of NICU and MICU studies were heterogeneous including different neurovascular diseases, which partly explains the wide range of SAP incidence. The higher incidence in the majority of ICU studies compared to stroke units or acute floor studies is likely explained by the presence of mechanical ventilation, higher stroke severity causing higher rates of aspiration and stroke-induced immunodepression among ICU patients. The short-term mortality of SAP was increased among the mixed and stroke unit studies ranging between 10.1 and 37.3%. SAP was associated with worse functional outcome in the majority of stroke unit and floor studies. Mortality was less consistent among NICU and MICU studies. This difference could be due to the heterogeneity of ICU studies and the effect of small sample size or other independent risk factors for mortality such as the larger neurological deficit, mechanical ventilation, and age, which may simultaneously increase the risk of SAP and mortality confounding the outcomes of SAP itself. The pathophysiology of SAP is likely explained by aspiration combined with stroke-induced immunodepression through complex humeral and neural pathways that include the hypothalamic-pituitary-adrenal axis, parasympathetic and sympathetic systems. <b><i>Conclusions:</i></b> A unified definition of SAP, strict inclusion criteria, and the presence of a long-term follow-up need to be applied to the future prospective studies to better identify the incidence and prognosis of SAP, especially among ICU patients.

Từ khóa


Tài liệu tham khảo

10.1159/000210093

10.1161/CIR.0b013e31823ac046

10.1212/WNL.0b013e31822dc795

10.1212/01.wnl.0000263187.08969.45

10.1016/j.jstrokecerebrovasdis.2010.05.002

10.1038/nrneurol.2012.98

10.1161/01.STR.0000251441.89665.bc

10.1007/s12028-008-9051-5

10.1016/j.ajic.2005.06.011

10.1586/ern.09.72

10.1161/01.STR.0000063373.70993.CD

10.1016/j.jcrc.2010.09.006

10.1016/j.ajic.2008.03.002

10.1007/s12028-009-9285-x

10.1007/s00415-007-0520-0

10.1177/147323000603400310

10.1007/s004550000038

10.1161/STROKEAHA.110.597039

10.1016/S0140-6736(95)92638-0

10.1212/01.WNL.0000096395.80826.23

10.1164/ajrccm.165.7.2105078

10.1016/j.jcrc.2004.02.004

10.1159/000065512

10.1136/jnnp.2003.019075

10.1161/01.STR.0000258346.68966.9d

10.1038/nrn1765

10.1084/jem.20021098

10.1161/01.STR.0000240409.68739.2b

10.1159/000111499

10.1161/STROKEAHA.109.549618

10.1159/000205514

10.1161/STROKEAHA.107.493635

10.1111/j.1468-1331.2012.03818.x

10.1111/j.1365-2796.2004.01334.x

10.1084/jem.20011714

10.1002/eji.1830240508

10.1007/978-3-7091-6837-0_80

10.1007/978-3-7091-0603-7_9

10.1161/01.STR.31.2.410

10.1007/s11910-012-0284-5

10.1159/000338906

10.1097/00003246-199907000-00017

10.1159/000069171

10.1016/j.ejim.2005.11.010

10.1183/09031936.05.00096104

10.1007/s004150170048

10.1186/1471-2377-11-110

10.1179/016164111X13007856084205

10.1016/j.jns.2011.04.001

10.1212/01.WNL.0000047344.28843.EB

10.1179/174313208X300422

10.1007/s12028-011-9638-0

10.1186/1472-6963-11-289

10.1016/S0967-5868(03)00022-5

10.1111/j.1468-1331.2006.01210.x

10.1111/j.1468-1331.2008.02400.x

10.1093/ageing/afj019

10.1007/s00415-010-5558-8

10.1097/PHM.0b013e31823caa8d

10.1161/STROKEAHA.110.599738

10.1136/jnnp.2009.182394

10.1161/STROKEAHA.109.558759

10.1046/j.1468-1331.2003.00749.x

10.1097/PHM.0b013e31824661a9

10.1159/000289350

10.1016/j.jstrokecerebrovasdis.2009.02.009

10.1212/WNL.0b013e31823152b1

10.1016/S0022-510X(99)00261-0

10.1161/01.STR.0000177529.86868.8d

10.1111/j.1468-1331.2008.02310.x

10.1161/01.STR.29.2.447

10.1161/STROKEAHA.110.613026

10.1212/01.WNL.0000046586.38284.60

10.1016/j.jstrokecerebrovasdis.2009.11.015

10.1161/STROKEAHA.106.478156

10.1007/s12603-009-0079-9

10.1016/j.jstrokecerebrovasdis.2009.01.009

10.1097/00004356-200512000-00002

10.1053/apmr.2002.33102

10.1007/s12028-008-9056-0

10.1161/CIRCULATIONAHA.107.181486

10.1002/14651858.CD008096

10.1161/01.STR.0000109041.89959.4C

10.1371/journal.pone.0002158

10.1161/01.STR.0000170644.15504.49

10.1161/STROKEAHA.107.499533

10.1002/14651858.CD008530.pub2

10.1111/j.1747-4949.2010.00555.x

10.1016/j.expneurol.2007.03.032

10.1159/000092922

10.1164/rccm.200309-1219OC

10.1007/s12325-012-0049-1

10.1086/653049

Thông tin
Thông tin xuất bản

Cerebrovascular Diseases

Tập 35 Số 5

430-443

Thông tin tác giả